Enabling cell culture, cell production and medical devices—

Press Releases

• 11 October 2007: 3DM, Inc. is acquired by its Japanese collaborator, 3DMatrix Japan, Ltd., and accelerates its clinical application and research reagent by the support of its new parent company.
  
  
• 1 August 2007: 3DM Inc to Present at First Albany Capital Regenerative Medicine Conference in NYC
  
  
• 16 July 2007: Robert Langer Wins National Medal of Science
  
  
• 2 April 2007: 3DM Inc. Technology Named Top Ten Emerging Technologies for 2007 by Technology Review Magazine for Nanohealing
  
  
• 6 September 2006: 3DM Inc. Welcomes Leading Cardiac and Orthopedic Clinical Researchers to its Clinical Advisory Board
  
  
• 31 July 2006: 3DM Inc. to Keynote at Dow Jones / Wall Street Journal Healthcare Innovations Conference; Demonstrating the Power of Biomaterial Scoffolds in Regenerative Medicine
  
  
• 15 March 2006: 3DM Inc. to Showcase Next Generation Nanobiomaterials at 2006 Society for Biomaterials & PTEI Regenerative Medicine World Congress
  
  
• 2 November 2005: 3DM Inc. Founders Awarded $6.5million NIH Program Grant for Regenerative Medicine & Tissue Engineering Research
  
  
• 1 August 2005: 3DM Inc. to Present on Orthopedic Biomaterials at the Dow Jones Venturewire Healthcare Ventures Conference
  
  
• 21 July 2005: BD™ PuraMatrix™ Synthetic Hydrogels Featured in
  BD Biosciences Inaugural Web Seminar Series
  
  
• 25 May 2005: 3DM Inc. to Present Stem Cell Culture Benefits of PuraMatrix Hydrogels at International Society for Stem Cell Research Conference
  
  
• 21 Feb 2005: 3DM Inc. Invited to Present on Orthopedic & Cardiac Regeneration at Windhover Convergence: Drug Device Conference
  
  
• 28 Oct 2004: 3DM Inc. Secures $1.7 Million Financing For Clinical Development of PuraMatrix™ Hydrogels
  
  
• 26 Sept 2004: 3DM Inc. Launches PuraMatrix™ Hydrogels Through Worldwide Partnership with BD Biosciences
  
  
• 8 July 2004: PuraMatrix™ Hydrogels Win Prestigious R&D100 Life Science Award: Most technologically significant new product impacting medical & life science product launched in the past year
  
  
• 1 March 2004: PuraMatrix™ Hydrogels Win International Awards for Biomaterial Nanotechnology & Regenerative Medicine: Most innovative new product to impact biotechnology, drug discovery, and medical devices
  
  
• 9 Dec 2003: 3DM Inc. Launches PuraMatrix™ Synthetic Hydrogels at American Society for Cell Biology (ASCB)Conference, Major Advance In 3-D Cell Culture and Defined Drug Discovery Assays
  
  
• 21 Aug 2003: 3DM Inc. PuraMatrix™ Synthetic Extracellular Matrix featured in journal Nature

News Articles

• Nanotech helps blind hamsters see
  BBC News, March 14, 2006
  Nanotechnology has restored the sight of blind rodents, a new study shows.
  
  
• Hamster Study Shows Nanofibers Knit Severed Neurons Together, Restore Vision
  ScientificAmerican.com, March 14, 2006
  
  
• Brain-Healing Nanotechnology
  Technology Review, March 14, 2006
  A ground-breaking treatment could restore lost abilities to stroke victims and others.
  
  
• Nanotechnology May Repair Damaged Brains
  Forbes.com, 03.14.06, 12:00 AM ET
  
  
• MIT Researchers Restore Vision In Rodents Blinded By Brain Damage Using Nanotechnology
  Nanotechwire.com, 3/14/2006 3:45:59 PM
  
  
• Nanotech restores vision in hamsters
  MSNBC, 8:02 p.m. ET March 13, 2006
  Synthetic mesh may someday be used for human brain injuries
  
  
• Optic nerve regrown with a nanofibre scaffold
  13 March 2006, NewScientist.com news service Paul Marks.
  Optic nerve regeneration and functional return with PuraMatrix nanofibre peptide scaffolds.
  
  
• MIT researchers restore vision in rodents blinded by brain damage
  Deborah Halber, News Office Correspondent, March 13, 2006
  First nanotechnology solution to repair and restore brain and vision function.
  
  
• Nanomedicine's Promise Is Anything but Tiny
  By Rick Weiss; Washington Post Staff Writer; Monday, January 31, 2005; Page A08  
  The nanofibers turn the liquid in which they are suspended into a therapeutic gel, which in experiments with cultured cells spurred neuron growth and inhibited scar formation. Moreover, rats and mice that got injections of the liquid a day after spinal cord injuries were more likely to recover the ability to walk than untreated animals.
  
  
• Chemical & Engineering News (ISSN 0009-2347): January 3, 2005
  MATERIALS POTPOURRI: Regenerative medicine meets nanotechnology; Nanomaterials built from a simple family of self-assembling molecules may offer hope for treating serious injuries such as stroke and spinal cord trauma. http://pubs.acs.org/cen/nanofocus/top/83/8301materials.html
  
  
• The VC Deal Newsletter  http://www.thedeal.com/NASApp/cs/CS?pagename=TheDeal/TDDArticle/
  StandardArticle&bn=NULL&c=TDDArticle&cid=1098397175628
  
  
• Medicine on a small scale: How molecular medicine can benefit from self-assembled and nanostructured materials
  EMBO Reports, Vol 4, Number 11 (Jan 2004) [Nanotechnology, nanomedicine, drug delivery]
  
  
• Biology's New Dimension
  Nature, Vol 424 (21 Aug 2003) [3D Cell Culture, Cancer Research, NIH Funding]
  
  
• Goodbye, Flat Biology
  Nature, Vol 424 (21 Aug 2003) [Editorial on trends in cell-based assays & biological research]
  
  
• Self-Assembling Peptide Hydrogel Shows Potential for Cartilage Tissue Repair
  Materials Connections: Research News, Materials Research Society (Sept. 2002)
  
  
• Molecular-scale biomimicry Nature Biotechnology 20, 30 - 31 (2002); William L. Murphy & David J. Mooney
  The design of self-assembling biomaterials that mimic complex biological structures represents a considerable challenge. This is perhaps not surprising when one considers that such structures have undergone millions of years of evolutionary optimization. Fortunately for us, biomimetics research is proceeding on a rather faster time scale, as demonstrated by a recent paper in Science by Stupp and colleagues 1. They report a molecule that self-assembles into a nanostructured gel and mimics some of the key properties of the human bone extracellular matrix (ECM). Materials based on this approach may prove useful in the regeneration of bony tissues.
  
  
• New Gel Could Lead to Cartilage Repair
  ScienceNews [Chondrocyte and osteoblast growth on nanofiber scaffolds]
  
  
• Biological Scaffold Allows Nerve Cells to Grow and Form Connections
  News: Biomedical Engineering, The Whitaker Foundation (June 2000) [Neurite outgrowth assay]
  
  
• One-Upping Nature's Materials: Striving for designer substances that build themselves from individual molecutles
  ScienceNews (Dec. 2000)
  
  
• Biomaterials for Growing Mammalian Cells
  A to Z of Materials
  The Australian Ceramic Society
  
  
• Technique Could Improve Cartilage Repair
  MIT News
  
  
• Cartilage Repair
  MIT Technology Insider
  Lab News
  
  
• Scientists and Engineers Together Revolutionizing Human Health
  MIT Spectrum (Spring 2002)

3DM/PuraMatrix™ Conference Presentations

• BioNanotechnology Conference, the international conference where biotech and nanotechnology converge, organized by Nano Science & Technology Institute
  http://www.comppub.com/BioNano2005/
  
  
• Windhover, the publishers of Start-Up and In Vivo medical ventures publications and IN3 Conferences,  have created Convergence: Drug Device Summit 
  http://www.windhover.com/dotcom/conferences/index.asp?page=convergence
  
  
• National Academy of Sciences Conference: Designing Nanostructures at the Interface Between Biomedical and Physical Systems Pre-Conference ( September 18-19, 2004 ). A good summary of Self-Assembling Peptide Biomaterials, Extracellular Matrix Nanostructures, and applications in Regenerative Medicine and Tissue Engineering by Samuel Stupp , Northwestern University
  http://www.nyas.org/ebriefreps/main.asp?intSubsectionID=1245
  http://progressive.playstream.com/nakfi/progressive/Pre-Conference/stupp/HTML/index.htm
  
  
• Cambridge Healthtech Institute Pharmaceutical Strategy Licensing & Partnering Congress
  http://www.healthtech.com/2004/lic/day1.asp
  
  
  ^Top^

Market Reports Featuring 3DM PuraMatrix

• Start-Up: Windhover's Review of Emerging Medical Ventures, 04/01/2005 , page 39
  Emerging Company Profile; Convergence (Devices and Biology) ; Orthopedic Implants ; Regenerative Medicine
  The field of tissue engineering has long sought a synthetic version of the extracellular matrix and 3DM Inc. may just have found the ideal synthetic nano-scaffold to fill the void. The company's founders-many of whom come from the Massachusetts Institute of Technology (MIT)-make up a "Who's Who" of biomaterials and tissue engineering.
  http://sis.windhover.com/windbuy/lpext.dll/windbuy/su/2005/2005900080.htm?f=templates&fn=document-frame.htm&q=puramatrix&x=Advanced&2.0#LPHit1
  
  
• Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, 2004-2014; (published April 2005) http://www.the-infoshop.com/study/med29226_tissue_engineering_toc.html
  
  
• Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies and Market Opportunities, 2003-2013, report S505 (published August 2003) http://www.mediligence.com/rpt-s505.htm
  
  
• Nanotechnology & MEMS: Current Medical Technologies, Applications & Market Opportunities, 2002-2012, report T601 (published January 2003) http://www.mediligence.com/rpt-t601.htm
  
  
• Cell Therapy, Tissue Engineering and Regeneration Showing Proof-of-Concept, Encouraging Continued Investment and Acquisition, According to New Report from MedMarket Diligence, LLC http://www.mediligence.com/PR/PR04-05.htm
  
  
• Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi
  Description: Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi, is a new report which provides an in-depth analysis of three technological innovations that are being heralded to revolutionize the drug discovery process by rapidly expediting drug discovery research. This report focuses on lab-on-a-chip (LOC) devices, nanotechnology and RNA interference drug discovery technologies that are increasingly being used to identify novel drug targets and to successfully reduce R&D timelines. http://www.researchandmarkets.com/reports/298295/298295.htm
  Table of Contents
  
  
• The Impact of Nanotechnology in Drug Discovery: Global Developments, Market Analysis and Future Prospects; NanoMarkets, Jan 2004; This report will be of vital interest to strategic planners, marketing managers and product development managers at all pharmaceutical, diagnostic, life science and biotechnology companies that may be interested in nanotechnology. This report may also benefit individuals and investors who track advances in the evolving nanotechnology market, including venture capitalists, healthcare equity analysts, academic research and scientific staff. http://www.researchandmarkets.com/reportinfo.asp?report_id=227590&t=d&cat_id=4
  
  
• Tissue Engineering: Technology, Trends, and Market Opportunities
  Drug and Market Development Publishing ; September 1, 2004; 120 Pages - Pub ID: DSMD1049331
  Abstract: This Report provides an up-to-date, comprehensive analysis of the tissue engineering industry. The Report presents an analysis of core tissue engineering technology (cells, materials, and manufacturing) and evaluates both the technical and market challenges and opportunities. In addition, the Report provides a clear understanding of the complexities of product development, the potential impact of new technical advances, and the necessary context for business planning. This Report provides the critical knowledge necessary to succeed in this developing market. http://www.marketresearch.com/product/display.asp?productid=1049331&xs=r

Home  |  Products  |  Technology  |  FAQs  |  Publications  |  Company  |  News  |  Contact

PuraMatrix is a registered trademark of 3DM Inc. Cambridge, Massachusetts, USA
contact@puramatrix.com     877-430-9595     Copyright 2001-2004 All rights reserved.